Founders get an actual readiness score before emailing investors. PropelRx runs diagnostics across financials, narrative, structure, timing and reputation—then tells you if you're ready to raise capital. This isn't a CRM with AI bolted on. It's infrastructure built specifically for Seed through Series B fundraising.
Outreach gets locked behind a readiness threshold. Sounds annoying—until you realize it's saving you from burning relationships with investors you'll need later. Clear that bar and PropelRx builds investor target lists with alignment percentages. These match signals go beyond usual sector tags. One example: Northbridge Ventures at 87% alignment. You can simulate campaigns before launching them.
The trial runs three days. You'll see your capital readiness status and explore investor matches. After that it's $199 monthly for execution access. Pro tier costs $299—includes API integrations and multi-raise coordination. There's also a 3.95% success fee on close, capped at $200K. No equity taken. PropelRx positions this against Y Combinator's 7% equity or typical investment bank rates around 5%.
Solo founders raising a Series A will probably appreciate structured workflow more than someone who's done this five times. PropelRx tracks engagement and monitors signals as conversations progress. Data room gating keeps materials from floating around before you're ready. It brings institutional discipline to a process that usually feels like organized chaos.
